Senior Director, US Medical Affairs, Lymphoma

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Senior Director will support US Golcadomide and BCL6-LDD and report to the Executive Director, Lymphoma Medical Product Lead. This headquarters-based role leads a multidisciplinary team of physicians, pharmacists, and scientists. The Senior Director provides scientific and medical leadership for approved and investigational lymphoma products, with a primary focus on golcadomide and BCL6-LDD. The role also leads integrated US Medical planning in partnership with Global Medical, Commercial, Clinical Research and Development, Regulatory, Translational Development, and Market Access.

The Senior Director helps shape and execute the US lymphoma medical strategy in alignment with US and Global Medical priorities. The role oversees the lymphoma medical plan, leads the US team, and coordinates evidence generation, including BMS-sponsored Medical Affairs studies, investigator-sponsored research, and external collaborations. The Senior Director also partners with Global Medical and US cross-functional teams to prepare for new product and indication launches.

Key Responsibilities

Essential functions include, but are not limited to:

• Medical Strategy and Execution:
  Lead the development and execution of the US Lymphoma Medical Affairs strategy and tactical plan. Partner with US and Global stakeholders to set priorities, allocate resources, and monitor performance.

• Launch Readiness:
  Lead US Medical launch planning for golcadomide, BCL6-LDD, and future products or indications. Align evidence generation, scientific communications, medical education, field readiness, external engagement, and operations with US and Global partners.

• Therapy Implementation:
  Lead or support site readiness, safe administration, toxicity management, long-term follow-up, and expanded access programs for new lymphoma therapies, as appropriate.

• Training:
  Oversee high-quality lymphoma training for Medical, Sales, and other functions. Topics may include the disease and standard of care, competitive landscape, BMS-sponsored trials, and key publications.

• External Scientific Engagement:
  Serve as a key US Medical contact for healthcare professionals, investigators, KOLs, advisory boards, advocacy organizations, and cooperative groups. Represent BMS at congresses and scientific meetings, and provide compliant scientific direction for external engagements and lymphoma assets.

• Evidence Generation and Publications:
  Lead evidence-generation and publication activities for inline and pipeline lymphoma assets. Activities may include BMS-sponsored Medical Affairs studies, investigator-sponsored research, registries, digital health studies, and external collaborations. Ensure appropriate review, budget and resource oversight, timely delivery, quality, publication, and Good Clinical Practice compliance.

• Cross-Functional and Global
  
  Collaboration:
  
  Partner across US and Global Medical, Commercial, Clinical Development, Regulatory, Market Access, Pharmacovigilance, Statistics, Translational Research, Manufacturing and Quality, Project Leadership, and Field Medical to align priorities and advance the US lymphoma medical strategy.

• Team Leadership and Development:
  Lead the multidisciplinary Lymphoma Medical Affairs…